The U.S. Judicial Panel on Multidistrict Litigation recently made pivotal decisions in the landscape of spinal cord stimulator lawsuits. It has transferred cases against Abbott Laboratories and Nevro to the Northern Districts of Illinois and California, respectively. This move is intended to streamline proceedings and ensure more efficient handling of the intricate legal matters involved.
Judge Lindsay Jenkins in the Northern District of Illinois will oversee the Abbott Laboratories cases. Abbott faces allegations concerning the safety and effectiveness of its spinal cord stimulators, which are used to manage chronic pain. The suits claim that the devices have led to adverse health outcomes, including infections and device malfunctions. Meanwhile, Judge Haywood Gilliam in the Northern District of California is set to manage the suits against Nevro, another company under scrutiny for similar issues regarding its spinal cord stimulators.
The decision to distribute these cases across different jurisdictions reflects an effort to mitigate the complexities and volume of claims. Concentrating related lawsuits under designated judges often results in more consistent rulings and streamlined discovery processes.
Details about the panel’s order can be found here. Additionally, reports indicate that these decisions align with similar multidistrict litigation strategies used in other pharmaceutical and medical device cases.
This development highlights the ongoing scrutiny of medical devices that fail to meet expected safety standards. With courts now poised to address the allegations more comprehensively, both Abbott and Nevro face significant legal scrutiny as these cases proceed in Illinois and California.